Impact of injection time and protein modality on particle formation when using closed system transfer devices

John F Seeler1, Bruce D Mason1, Vish Swami1

  • 1Drug Product and Device Development, Takeda Pharmaceutical Company, 200 Shire Way, Lexington, MA, 02421, USA.

Abstract